The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees — fell by 2.8% in last year’s fourth quarter, the largest decline ever measured by SSR Health, a ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
On August 15, 2024, the Centers for Medicare and Medicaid Services (CMS) released the negotiated prices, or Maximum Fair Prices (MFPs), for the first 10 pharmaceutical products selected for ...
New research from Phil Levine, an economist and college cost transparency advocate, shows that the net price of four-year tuition continues to drop or remain steady for all but the highest-income ...
Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...
The IRA directs HHS to identify annually a limited number of costly medications and set their MFPs for Medicare. Although termed a negotiation, the IRA effectively empowers the secretary to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results